Literature DB >> 35156191

Voxelotor and albuminuria in adults with sickle cell anaemia.

Jin Han1,2, Robert E Molokie1,3, Faiz Hussain1, Franklin Njoku1, Victor R Gordeuk1, Santosh L Saraf1.   

Abstract

Entities:  

Keywords:  albuminuria; haemolysis; kidney disease; sickle cell anaemia; voxelotor

Mesh：

Substances：

Year:  2022        PMID： 35156191      PMCID： PMC9149116          DOI： 10.1111/bjh.18076

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  9 in total

Review 1.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

2.  Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Authors:  Inmaculada Aban; Sujatha Baddam; Lee M Hilliard; Thomas H Howard; Daniel I Feig; Jeffrey D Lebensburger
Journal:  Blood       Date:  2016-12-05       Impact factor: 22.113

3.  Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease.

Authors:  Mark T Gladwin; Tamir Kanias; Daniel B Kim-Shapiro
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

4.  A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.

Authors:  Elliott Vichinsky; Carolyn C Hoppe; Kenneth I Ataga; Russell E Ware; Videlis Nduba; Amal El-Beshlawy; Hoda Hassab; Maureen M Achebe; Salam Alkindi; R Clark Brown; David L Diuguid; Paul Telfer; Dimitris A Tsitsikas; Ashraf Elghandour; Victor R Gordeuk; Julie Kanter; Miguel R Abboud; Joshua Lehrer-Graiwer; Margaret Tonda; Allison Intondi; Barbara Tong; Jo Howard
Journal:  N Engl J Med       Date:  2019-06-14       Impact factor: 91.245

5.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

6.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

7.  Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution.

Authors:  Tanja Johannes; Egbert G Mik; Boris Nohé; Klaus E Unertl; Can Ince
Journal:  Am J Physiol Renal Physiol       Date:  2006-10-31

8.  Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.

Authors:  M von Eynatten; M Baumann; U Heemann; D Zdunek; G Hess; P P Nawroth; A Bierhaus; P M Humpert
Journal:  Eur J Clin Invest       Date:  2009-11-11       Impact factor: 4.686

9.  Effects of Renin-Angiotensin Blockade and APOL1 on Kidney Function in Sickle Cell Disease.

Authors:  Jin Han; Andrew Srisuwananukorn; Binal N Shah; Robert E Molokie; James P Lash; Victor R Gordeuk; Santosh L Saraf
Journal:  EJHaem       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.